Trends in linezolid susceptibility patterns in 2002: Report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program

This publication has 13 references indexed in Scilit:

• Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus
  Journal of Antimicrobial Chemotherapy, 2004
• Antimicrobial Resistance to Linezolid
  Clinical Infectious Diseases, 2004
• Linezolid Resistance in SequentialStaphylococcus aureusIsolates Associated with a T2500A Mutation in the 23S rRNA Gene and Loss of a Single Copy of rRNA
  The Journal of Infectious Diseases, 2004
• Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific
  Journal of Antimicrobial Chemotherapy, 2003
• Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox® antimicrobial potency study (ZAPS-Europe)
  Clinical Microbiology & Infection, 2002
• Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
  Antimicrobial Agents and Chemotherapy, 2002
• Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)
  The Brazilian Journal of Infectious Diseases, 2002
• A multicenter evaluation of linezolid antimicrobial activity in North America
  Diagnostic Microbiology and Infectious Disease, 2002
• Oxazolidinone antibiotics
  The Lancet, 2001
• Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox® Antimicrobial Potency Study (ZAPS) in the United States
  Diagnostic Microbiology and Infectious Disease, 2001